---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-165466"
form_type: "8-K"
ticker: "ABSI"
cik: "0001672688"
company_name: "Absci Corp"
filed_at: "2025-07-25T23:59:59+00:00"
generated_at: "2026-05-18T01:11:04.354108+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Absci prices $50M public offering of 16.67M shares at $3.00 per share

## Summary
- Offering of 16,670,000 shares at $3.00 per share; gross proceeds ~$50M.
- Net proceeds estimated at ~$46.7M (or ~$53.7M if underwriters' option exercised in full).
- Proceeds to fund internal programs, Integrated Drug Creation platform, and general corporate purposes.
- Underwriters: Morgan Stanley, J.P. Morgan, Jefferies, TD Securities; expected close July 28, 2025.
- Offer made under effective shelf registration statement on Form S-3 (File No. 333-267043).

## SEC filing metadata
- accession: 0001193125-25-165466
- form_type: 8-K
- ticker: ABSI
- cik: 0001672688
- company_name: Absci Corp
- filed_at: 2025-07-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1672688/000119312525165466/0001193125-25-165466-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1672688/000119312525165466/d65613d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-165466
- JSON: https://secwatch.observer/filing/0001193125-25-165466.json
- Plain text: https://secwatch.observer/filing/0001193125-25-165466.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.